Literature DB >> 6787080

Role of insulin in the intermediary metabolism of the activated thymic-derived lymphocyte.

J H Helderman.   

Abstract

The hypothesis that a role for insulin in the metabolism of T cells would be evident after cell activation when receptors appear was tested to validate the T cell model and to analyze the mechanism by which insulin may function in immunoregulation. Measuring the flux rates of 3-O-[methyl-3H]-D-glucose and aminoisobutyric acid, alpha-[1-14C], lactate production and oxidation, and glucose oxidation from carbon 1- and carbon 6-labeled substrates, it was determined that (a) mitogens such as phytohemagglutinin enhance basal T lymphocyte intermediary metabolism, (b) physiologic concentrations of insulin have no impact on the metabolism of unstimulated, cultured, receptor-negative lymphocytes, and (c) insulin provided to receptor bearing lymphocytes augments intermediary metabolism above mitogen stimulated levels. The importance of the pentose phosphate shunt pathway for energy metabolism in the stimulated lymphocyte was confirmed. These studies demonstrate that insulin has a classical physiologic role to play in the activated lymphocyte further validating the use of this cell to examine potential receptor defects in disorders of carbohydrate metabolism. By enhancing energy metabolism of stimulated lymphocytes, insulin serves biologic economy and thus may perform its immunoregulatory role.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6787080      PMCID: PMC370738          DOI: 10.1172/jci110199

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  The use of C14O2 yields from glucose-1- and -6-C14 for the evaluation of the pathways of glucose metabolism.

Authors:  J KATZ; H G WOOD
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

2.  Insulin action in isolated rat thymocytes. I. Binding of 125 I-insulin and stimulation of -aminoisobutyric acid transport.

Authors:  I D Goldfine; J D Gardner; D M Neville
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

3.  Characteristics of the human lymphocyte insulin receptor.

Authors:  J R Gavin; P Gorden; J Roth; J A Archer; D N Buell
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

4.  Direct action of insulin on plasma membrane ATPase activity in human lymphocytes.

Authors:  J W Hadden; E M Hadden; E E Wilson; R A Good; R G Coffey
Journal:  Nat New Biol       Date:  1972-02-09

5.  [The effect of insulin and several other factors on the glycolysis of human leukocytes measured in vitro].

Authors:  J A Antonioli; J P Felber; A Vannotti
Journal:  Acta Haematol       Date:  1967       Impact factor: 2.195

6.  Effect of phytohemagglutinin on lymphocyte membrane transport. 2. Stimulation of "facilitated diffusion" of 3-O-methyl-glucose.

Authors:  J H Peters; P Hausen
Journal:  Eur J Biochem       Date:  1971-04-30

7.  Glucocorticoid inhibition of glucose uptake by peripheral tissues: old and new evidence, molecular mechanisms, and physiological significance.

Authors:  A Munck
Journal:  Perspect Biol Med       Date:  1971       Impact factor: 1.416

8.  Insulin receptors in human circulating cells and fibroblasts.

Authors:  J R Gavin; J Roth; P Jen; P Freychet
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

9.  Insulin receptors in human circulating lymphocytes: application to the study of insulin resistance in man.

Authors:  J A Archer; P Gorden; J R Gavin; M A Lesniak; J Roth
Journal:  J Clin Endocrinol Metab       Date:  1973-04       Impact factor: 5.958

10.  The rapid induction by phytohemagglutinin of increased alpha-aminoisobutyric acid uptake by lymphocytes.

Authors:  J Mendelsohn; A Skinner; S Kornfeld
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  21 in total

1.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

2.  Lactate production is the major metabolic fate of glucose in splenocytes and is altered in spontaneously diabetic BB rats.

Authors:  C J Field; G Wu; M D Métroz-Dayer; M Montambault; E B Marliss
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities.

Authors:  M P Nair; E W Lewis; S A Schwartz
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

4.  Monocyte-T lymphocyte interaction for regulation of insulin receptors of the activated T lymphocyte.

Authors:  J H Helderman; R Ayuso; J Rosenstock; P Raskin
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 5.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 6.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 7.  Insulin receptor binding to blood cells: an outdated concept for clinical studies on insulin resistance?

Authors:  M J Müller
Journal:  Klin Wochenschr       Date:  1987-10-15

8.  Acute regulation of human lymphocyte insulin receptors. Analysis by the glucose clamp.

Authors:  J H Helderman
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  Effect of insulin and transferrin in the maintenance of the activated state of the T-lymphocyte induced by allo-antigen.

Authors:  J H Helderman; R Gruchalla; L E Edwards
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

Review 10.  Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival.

Authors:  Nancie J Maciver; Sarah R Jacobs; Heather L Wieman; Jessica A Wofford; Jonathan L Coloff; Jeffrey C Rathmell
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.